ALNY vs DEVS · P/E 76, rev $2.25B vs rev $25.8K
Alnylam Pharmaceuticals Inc (ALNY) versus DevvStream Corp. Common Stock (DEVS) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
DevvStream Corp. Common Stock (DEVS) is a pollution & treatment controls company listed on US.
Latest reported ALNY revenue for 2024-12-31 was $2.25B. Net income was -$278.2M. Revenue was up 23.0% from 2023-12-31 to 2024-12-31. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported DEVS revenue for 2025-07-31 was $25.8K. Net income was -$12.1M. DEVS currently screens at market cap $13.4M.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. DEVS currently screens at market cap $13.4M.
Not investment advice. Open the ALNY and DEVS stock pages for the full models.
Not investment advice.